舒泰神：注射用STSP-0601附条件上市申请于2025年6月获国家药监局受理

Core Viewpoint - The company Shuyou Shen (300204) has its conditional listing application for the injectable STSP-0601 accepted by the National Medical Products Administration (NMPA) in June 2025, currently undergoing the normal review process [1] Group 1 - The priority review and approval process for the listing registration application has a review time limit of 130 days [1] - Preliminary reviews by various professional departments have been completed, and the process has entered the next stage, indicating that the review is progressing normally [1] - The review and approval for STSP-0601 has not concluded, and updates on research and development projects will be provided in future regular reports and project progress announcements [1]